PDR001 Combination Therapy for Radioiodine-Refractory Thyroid Cancer

Clinical trial NCT04544111 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04544111
Sponsor: Memorial Sloan Kettering Cancer Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Thyroid Cancer Thyroid Cancer, Follicular Papillary Thyroid Cancer Follicular Thyroid Cancer Hurthle Cell Tumor Poorly Differentiated Thyroid Gland Carcinoma Hurthle Cell Thyroid Neoplasia

Start date: 2020-09-02
Primary completion: 2026-09-02
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.